Samuel B. Rollins
Corporate Officer/Principal chez vTv Therapeutics LLC
Profil
Samuel B.
Rollins is currently a Senior Vice President-Intellectual Property at vTv Therapeutics LLC.
Prior to this, he was a Vice President-Intellectual Property at VTVX Holdings I LLC and vTv Therapeutics, Inc. He also worked as an Associate at Kilpatrick Stockton LLP.
Rollins holds a doctorate degree from Colorado State University, an undergraduate degree from The University of North Carolina at Charlotte, and a graduate degree from Wake Forest University School of Law.
Postes actifs de Samuel B. Rollins
| Sociétés | Poste | Début |
|---|---|---|
vTv Therapeutics LLC
 vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | Corporate Officer/Principal | - |
Anciens postes connus de Samuel B. Rollins
| Sociétés | Poste | Fin |
|---|---|---|
| VTV THERAPEUTICS INC. | Corporate Officer/Principal | 01/12/2021 |
Kilpatrick Stockton LLP
 Kilpatrick Stockton LLP Miscellaneous Commercial ServicesCommercial Services Kilpatrick Stockton LLP offered legal counsel for corporations. Its legal services encompass the fields of business and finance, construction and infrastructure, government and regulation, intellectual property, labor and employment, and litigation. The company was founded in 1997 and was headquartered in Atlanta, GA. | Corporate Officer/Principal | - |
VTVX Holdings I LLC
 VTVX Holdings I LLC Miscellaneous Commercial ServicesCommercial Services VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC. | Corporate Officer/Principal | - |
Formation de Samuel B. Rollins
| The University of North Carolina at Charlotte | Undergraduate Degree |
| Colorado State University | Doctorate Degree |
| Wake Forest University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VTV THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
VTVX Holdings I LLC
VTVX Holdings I LLC Miscellaneous Commercial ServicesCommercial Services VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC. | Commercial Services |
Kilpatrick Stockton LLP
Kilpatrick Stockton LLP Miscellaneous Commercial ServicesCommercial Services Kilpatrick Stockton LLP offered legal counsel for corporations. Its legal services encompass the fields of business and finance, construction and infrastructure, government and regulation, intellectual property, labor and employment, and litigation. The company was founded in 1997 and was headquartered in Atlanta, GA. | Commercial Services |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | Health Technology |
